Lyra Therapeutics, Inc. Annual Return On Equity in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Lyra Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2023.
  • Lyra Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -144 %, a 99.9% decline year-over-year.
  • Lyra Therapeutics, Inc. annual Return On Equity for 2023 was -74.1 %, a 1.72% decline from 2022.
  • Lyra Therapeutics, Inc. annual Return On Equity for 2022 was -72.9 %, a 13.5% increase from 2021.
  • Lyra Therapeutics, Inc. annual Return On Equity for 2021 was -84.3 %, a 9.91% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -74.1 -1.25 -1.72% Jan 1, 2023 Dec 31, 2023
2022 -72.9 +11.4 +13.5% Jan 1, 2022 Dec 31, 2022
2021 -84.3 -7.6 -9.91% Jan 1, 2021 Dec 31, 2021
2020 -76.7 -90.6 -650% Jan 1, 2020 Dec 31, 2020
2019 13.9 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.